Sophie Georgin-Lavialle Selected Research

Necrosis

12/2021	Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic review.
1/2021	Chronic hepatic involvement in the clinical spectrum of A20 haploinsufficiency.
10/2019	Specific changes in faecal microbiota are associated with familial Mediterranean fever.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sophie Georgin-Lavialle Research Topics

Disease

21	Familial Mediterranean Fever (Periodic Disease) 05/2024 - 01/2017
14	Amyloidosis 09/2023 - 10/2014
13	Inflammation (Inflammations) 10/2023 - 01/2017
9	Fever (Fevers) 04/2024 - 11/2010
8	VEXAS syndrome 02/2024 - 10/2021
6	Mevalonate Kinase Deficiency 04/2024 - 01/2018
6	Infections 12/2023 - 07/2015
6	Neoplasms (Cancer) 10/2023 - 07/2015
6	COVID-19 01/2023 - 01/2021
6	Mastocytosis 01/2016 - 03/2010
5	autosomal dominant familial Periodic fever 04/2024 - 01/2021
5	Arthralgia (Joint Pain) 10/2023 - 01/2011
5	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 01/2020
4	Cryopyrin-Associated Periodic Syndromes 11/2023 - 01/2020
4	Chronic Kidney Failure (Chronic Renal Failure) 09/2023 - 04/2021
4	Rheumatoid Arthritis 06/2021 - 08/2010
3	Proteinuria 01/2023 - 10/2014
3	Necrosis 12/2021 - 10/2019
3	Congenital heart block 12/2017 - 10/2004
2	Rheumatic Fever (Acute Articular Rheumatism) 05/2024 - 10/2023
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 03/2024 - 01/2015
2	Musculoskeletal Diseases (Musculoskeletal Disease) 12/2023 - 06/2021
2	Diarrhea 10/2023 - 01/2019
2	Rare Diseases (Rare Disease) 09/2023 - 07/2014
2	Renal Insufficiency (Renal Failure) 09/2023 - 12/2020
2	Persistent Infection 01/2023 - 06/2021
2	Disease Progression 01/2023 - 01/2021
2	Hypertension (High Blood Pressure) 01/2023 - 06/2021
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023 - 06/2021
2	Neonatal Systemic lupus erythematosus 10/2022 - 12/2015
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 01/2019
2	Immunoglobulin Light-chain Amyloidosis 11/2021 - 10/2014
2	Splenomegaly 10/2021 - 01/2014
2	Hereditary Autoinflammatory Diseases 01/2021 - 01/2020
2	Anemia 01/2019 - 06/2016
2	Arthritis (Polyarthritis) 12/2018 - 07/2015
2	Erdheim-Chester Disease 03/2013 - 11/2010
2	Systemic Mastocytosis 01/2013 - 07/2012
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2011 - 10/2004
1	Mesothelioma 01/2024
1	Ichthyosis (Xeroderma) 10/2023
1	Hypersensitivity (Allergy) 10/2023
1	Atopic Dermatitis (Atopic Eczema) 10/2023
1	Kidney Diseases (Kidney Disease) 09/2023
1	Vasculitis (Vasculitides) 01/2023
1	Obesity 01/2023
1	Morbid Obesity 01/2023
1	Sarcoidosis (Schaumann Disease) 01/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2023
1	Skin Diseases (Skin Disease) 10/2022
1	Chronic Disease (Chronic Diseases) 08/2022
1	Pneumonia (Pneumonitis) 04/2022

Drug/Important Bio-Agent (IBA)

21	AA amyloidosisIBA 03/2024 - 10/2014
9	EnzymesIBA 02/2024 - 06/2016
8	Colchicine FDA LinkGeneric 01/2024 - 01/2017
8	Interleukin-1 (Interleukin 1)IBA 11/2022 - 11/2010
7	Amyloid (Amyloid Fibrils)IBA 09/2022 - 11/2018
7	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2021 - 03/2013
5	C-Reactive ProteinIBA 09/2023 - 11/2010
5	AntibodiesIBA 10/2022 - 10/2004
5	InterleukinsIBA 05/2021 - 01/2015
4	canakinumab FDA Link 04/2024 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 11/2023 - 03/2017
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 01/2011
4	InflammasomesIBA 10/2022 - 01/2017
3	Azacitidine (5 Azacytidine)FDA Link 12/2023 - 11/2021
3	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2023 - 08/2010
3	Histamine (Histamine Dihydrochloride)FDA Link 10/2023 - 01/2019
3	AutoantibodiesIBA 01/2023 - 02/2019
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2019
3	Rituximab (Mabthera)FDA Link 01/2023 - 01/2015
3	Interleukin-6 (Interleukin 6)IBA 10/2019 - 11/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 06/2015
2	GlucocorticoidsIBA 12/2023 - 01/2022
2	Oxygen (Dioxygen)IBA 01/2023 - 04/2022
2	SteroidsIBA 10/2022 - 01/2022
2	Prealbumin (Transthyretin)IBA 09/2022 - 10/2014
2	Dexamethasone (Maxidex)FDA LinkGeneric 04/2022 - 01/2015
2	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2021 - 05/2014
2	Tryptophan (L-Tryptophan)FDA Link 01/2019 - 01/2016
2	Tyrosine Kinase InhibitorsIBA 01/2016 - 07/2012
2	Tryptases (Tryptase)IBA 01/2014 - 01/2013
2	masitinibIBA 07/2012 - 01/2011
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 05/2024
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2024
1	Janus Kinase InhibitorsIBA 12/2023
1	VaccinesIBA 12/2023
1	baricitinibIBA 10/2023
1	PyrinIBA 10/2022
1	AmyloseIBA 09/2022
1	tocilizumab (atlizumab)FDA Link 04/2022

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2011
2	Biological Therapy 09/2023 - 12/2020
2	Kidney Transplantation 09/2023 - 12/2020
1	Transplantation 09/2023
1	Gastrectomy 01/2023
1	First Aid (Aids, First) 01/2023
1	Transitional Care 08/2022
1	Artificial Respiration (Mechanical Ventilation) 04/2022